CYP 10.2% 22.0¢ cynata therapeutics limited

Ann: Investor Presentation, page-594

  1. 4,030 Posts.
    lightbulb Created with Sketch. 296
    I will set you a challenge then to declare.

    "Everything I am researching says beware of tumorous cell splitting mutations?"

    That is my statement so I now want you to declare that there is..... no possibility of tumorous mutations with iPSC therapy?

    Declare it with proof of actual therapy in humans and we can move on.

    I get it that we all see stem cells as the golden ticket.

    Some are just a bit more greedy and the FDA need to go with nature before artificial when something is new to approval.
    Last edited by gavint66: 25/06/24
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
-0.025(10.2%)
Mkt cap ! $42.42M
Open High Low Value Volume
24.0¢ 24.0¢ 22.0¢ $39.05K 169.5K

Buyers (Bids)

No. Vol. Price($)
1 14222 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 100000 1
View Market Depth
Last trade - 15.17pm 05/08/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.